A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

IsraelRecruitingPHASE3

Conditions

Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Teva Investigational Site 12087, Phoenix, Arizona, United States

  • Teva Investigational Site 12144, Phoenix, Arizona, United States

  • Teva Investigational Site 12104, Tucson, Arizona, United States

  • Teva Investigational Site 12146, Tucson, Arizona, United States

  • Teva Investigational Site 12102, Little Rock, Arkansas, United States

  • Teva Investigational Site 12154, Encinitas, California, United States

  • Teva Investigational Site 12103, Huntington Beach, California, United States

  • Teva Investigational Site 12068, La Palma, California, United States

  • Teva Investigational Site 12152, Laguna Niguel, California, United States

  • Teva Investigational Site 12145, Long Beach, California, United States

  • Teva Investigational Site 12088, Los Angeles, California, United States

  • Teva Investigational Site 12094, Los Angeles, California, United States

  • Teva Investigational Site 12161, Northridge, California, United States

  • Teva Investigational Site 12105, Oxnard, California, United States

  • Teva Investigational Site 12101, Sacramento, California, United States

  • Teva Investigational Site 12064, San Jose, California, United States

  • Teva Investigational Site 12109, Upland, California, United States

  • Teva Investigational Site 12070, Vista, California, United States

  • Teva Investigational Site 12091, Walnut Creek, California, United States

  • Teva Investigational Site 12142, Lakewood, Colorado, United States

  • Teva Investigational Site 12098, Lake City, Florida, United States

  • Teva Investigational Site 12118, Lake Worth, Florida, United States

  • Teva Investigational Site 12079, Melbourne, Florida, United States

  • Teva Investigational Site 12071, Miami, Florida, United States

  • Teva Investigational Site 12074, Miami, Florida, United States

  • Teva Investigational Site 12086, Miami, Florida, United States

  • Teva Investigational Site 12061, Miami, Florida, United States

  • Teva Investigational Site 12097, Miami, Florida, United States

  • Teva Investigational Site 12092, Miami Lakes, Florida, United States

  • Teva Investigational Site 12076, North Miami Beach, Florida, United States

  • Teva Investigational Site 12095, Palmetto Bay, Florida, United States

  • Teva Investigational Site 12075, Pompano Beach, Florida, United States

  • Teva Investigational Site 12078, Tampa, Florida, United States

  • Teva Investigational Site 12175, Conyers, Georgia, United States

  • Teva Investigational Site 12156, Boise, Idaho, United States

  • Teva Investigational Site 12162, Westchester, Illinois, United States

  • Teva Investigational Site 12169, Shreveport, Louisiana, United States

  • Teva Investigational Site 12081, Nottingham, Maryland, United States

  • Teva Investigational Site 12106, Towson, Maryland, United States

  • Teva Investigational Site 12157, White Marsh, Maryland, United States

  • Teva Investigational Site 12119, Boston, Massachusetts, United States

  • Teva Investigational Site 12073, Minneapolis, Minnesota, United States

  • Teva Investigational Site 12066, Richfield, Minnesota, United States

  • Teva Investigational Site 12149, Columbia, Missouri, United States

  • Teva Investigational Site 12108, St Louis, Missouri, United States

  • Teva Investigational Site 12089, St Louis, Missouri, United States

  • Teva Investigational Site 12158, Hastings, Nebraska, United States

  • Teva Investigational Site 12160, Las Vegas, Nevada, United States

  • Teva Investigational Site 12150, Las Vegas, Nevada, United States

  • Teva Investigational Site 12110, Jersey City, New Jersey, United States

  • Teva Investigational Site 12167, Buffalo, New York, United States

  • Teva Investigational Site 12115, Charlotte, North Carolina, United States

  • Teva Investigational Site 12085, Raleigh, North Carolina, United States

  • Teva Investigational Site 12063, Toledo, Ohio, United States

  • Teva Investigational Site 12178, Oklahoma City, Oklahoma, United States

  • Teva Investigational Site 12155, Tulsa, Oklahoma, United States

  • Teva Investigational Site 12170, Tulsa, Oklahoma, United States

  • Teva Investigational Site 12117, Clackamas, Oregon, United States

  • Teva Investigational Site 12151, Portland, Oregon, United States

  • Teva Investigational Site 12147, Horsham, Pennsylvania, United States

  • Teva Investigational Site 12072, Philadelphia, Pennsylvania, United States

  • Teva Investigational Site 12114, Pittsburgh, Pennsylvania, United States

  • Teva Investigational Site 12067, Columbia, South Carolina, United States

  • Teva Investigational Site 12111, Myrtle Beach, South Carolina, United States

  • Teva Investigational Site 12112, North Charleston, South Carolina, United States

  • Teva Investigational Site 12107, Rock Hill, South Carolina, United States

  • Teva Investigational Site 12083, Austin, Texas, United States

  • Teva Investigational Site 12060, Austin, Texas, United States

  • Teva Investigational Site 12077, Corsicana, Texas, United States

  • Teva Investigational Site 12159, Dallas, Texas, United States

  • Teva Investigational Site 12171, Dallas, Texas, United States

  • Teva Investigational Site 12090, Dallas, Texas, United States

  • Teva Investigational Site 12143, El Paso, Texas, United States

  • Teva Investigational Site 12168, Houston, Texas, United States

  • Teva Investigational Site 12176, Kerrville, Texas, United States

  • Teva Investigational Site 12080, Kingwood, Texas, United States

  • Teva Investigational Site 12096, McKinney, Texas, United States

  • Teva Investigational Site 12113, Mesquite, Texas, United States

  • Teva Investigational Site 12166, Sugar Land, Texas, United States

  • Teva Investigational Site 12084, Victoria, Texas, United States

  • Teva Investigational Site 12148, Pleasant View, Utah, United States

  • Teva Investigational Site 12082, Salt Lake City, Utah, United States

  • Teva Investigational Site 12153, South Ogden, Utah, United States

  • Teva Investigational Site 12093, Portsmouth, Virginia, United States

  • Teva Investigational Site 12062, Greenfield, Wisconsin, United States

  • Teva Investigational Site 20154, Buenos Aires, Argentina

  • Teva Investigational Site 20156, Buenos Aires, Argentina

  • Teva Investigational Site 20157, Córdoba, Argentina

  • Teva Investigational Site 20150, Córdoba, Argentina

  • Teva Investigational Site 20160, Florida, Vicente Lopez, Argentina

  • Teva Investigational Site 20145, Mar del Plata, Argentina

  • Teva Investigational Site 20151, Mar del Plata, Argentina

  • Teva Investigational Site 20161, Mendoza, Argentina

  • Teva Investigational Site 20146, Quilmes, Argentina

  • Teva Investigational Site 20148, Rosario, Argentina

  • Teva Investigational Site 20155, Rosario, Argentina

  • Teva Investigational Site 20147, San Juan Bautista, Argentina

  • Teva Investigational Site 20152, San Miguel de Tucumán, Argentina

  • Teva Investigational Site 20159, San Miguel de Tucumán, Argentina

  • Teva Investigational Site 20149, San Miguel de Tucumán, Argentina

  • Teva Investigational Site 20158, Santa Fe, Argentina

  • Teva Investigational Site 59248, Haskovo, Bulgaria

  • Teva Investigational Site 59251, Lovech, Bulgaria

  • Teva Investigational Site 59249, Montana, Bulgaria

  • Teva Investigational Site 59258, Montana, Bulgaria

  • Teva Investigational Site 59247, Pleven, Bulgaria

  • Teva Investigational Site 59259, Rousse, Bulgaria

  • Teva Investigational Site 59256, Sliven, Bulgaria

  • Teva Investigational Site 59246, Sofia, Bulgaria

  • Teva Investigational Site 59252, Sofia, Bulgaria

  • Teva Investigational Site 59257, Sofia, Bulgaria

  • Teva Investigational Site 59253, Sofia, Bulgaria

  • Teva Investigational Site 59245, Stara Zagora, Bulgaria

  • Teva Investigational Site 59254, Veliko Tarnovo, Bulgaria

  • Teva Investigational Site 59250, Vratsa, Bulgaria

  • Teva Investigational Site 54248, Brno, Czechia

  • Teva Investigational Site 54245, Jindřichův Hradec, Czechia

  • Teva Investigational Site 54246, Prague, Czechia

  • Teva Investigational Site 54249, Prague, Czechia

  • Teva Investigational Site 54244, Teplice, Czechia

  • Teva Investigational Site 54243, Varnsdorf, Czechia

  • Teva Investigational Site 32881, Ahrensburg, Germany

  • Teva Investigational Site 32880, Bendorf, Germany

  • Teva Investigational Site 32884, Berlin, Germany

  • Teva Investigational Site 32886, Berlin, Germany

  • Teva Investigational Site 32893, Delitzsch, Germany

  • Teva Investigational Site 32879, Frankfurt, Germany

  • Teva Investigational Site 32892, Frankfurt, Germany

  • Teva Investigational Site 32887, Leipzig, Germany

  • Teva Investigational Site 32876, Leipzig, Germany

  • Teva Investigational Site 32883, Leipzig - Nordost, Germany

  • Teva Investigational Site 32877, Magdeburg, Germany

  • Teva Investigational Site 32878, Mainz A. Rhein, Germany

  • Teva Investigational Site 32888, Neu-Isenburg, Germany

  • Teva Investigational Site 32890, Peine, Germany

  • Teva Investigational Site 32882, Rheine, Germany

  • Teva Investigational Site 32889, Witten, Germany

  • Teva Investigational Site 80207, Be’er Ya‘aqov, Israel

  • Teva Investigational Site 80206, Haifa, Israel

  • Teva Investigational Site 80208, Jerusalem, Israel

  • Teva Investigational Site 21133, Chihuahua City, Mexico

  • Teva Investigational Site 21134, Mexico City, Mexico

  • Teva Investigational Site 21137, Morelia, Mexico

  • Teva Investigational Site 21136, Tlalnepantla, Mexico

  • Teva Investigational Site 21135, Zapopan, Mexico

  • Teva Investigational Site 53582, Bialystok, Poland

  • Teva Investigational Site 53580, Bialystok, Poland

  • Teva Investigational Site 53578, Gdansk, Poland

  • Teva Investigational Site 53575, Lodz, Poland

  • Teva Investigational Site 53576, Lodz, Poland

  • Teva Investigational Site 53581, Maków Podhalański, Poland

  • Teva Investigational Site 53579, Poznan, Poland

  • Teva Investigational Site 53574, Tarnów, Poland

  • Teva Investigational Site 53577, Wroclaw, Poland

  • Teva Investigational Site 52149, Bucharest, Romania

  • Teva Investigational Site 52148, Craiova, Romania

  • Teva Investigational Site 52147, Oradea, Romania

  • Teva Investigational Site 52145, Timișoara, Romania

  • Teva Investigational Site 61089, Belgrade, Serbia

  • Teva Investigational Site 61090, Belgrade, Serbia

  • Teva Investigational Site 61093, Belgrade, Serbia

  • Teva Investigational Site 61092, Belgrade, Serbia

  • Teva Investigational Site 61088, Belgrade, Serbia

  • Teva Investigational Site 61094, Kragujevac, Serbia

  • Teva Investigational Site 61096, Niš, Serbia

  • Teva Investigational Site 61095, Novi Sad, Serbia

  • Teva Investigational Site 61091, Užice, Serbia

  • Teva Investigational Site 62102, Košice, Slovakia

  • Teva Investigational Site 62103, Martin, Slovakia

  • Teva Investigational Site 62104, Slovakia, Slovakia

  • Teva Investigational Site 62101, Spišská Nová Ves, Slovakia

  • Teva Investigational Site 82089, Adana, Turkey (Türkiye)

  • Teva Investigational Site 82085, Kirikkale, Turkey (Türkiye)

  • Teva Investigational Site 82088, Kocaeli, Turkey (Türkiye)

  • Teva Investigational Site 82087, Mersin, Turkey (Türkiye)

Study leads
  • Teva Medical Expert, MD

    Study Director

    Teva Branded Pharmaceutical Products R&D LLC